# PALI (Palisade Bio, Inc.) - SEC EDGAR Financial Statements

> Palisade Bio, Inc. reported $500K in revenue and a net loss of $43.70M for the trailing twelve months ended September 30, 2026, with a -9625.4% operating margin.

- Canonical: https://convexityos.com/fundamentals/PALI
- Markdown: https://convexityos.com/fundamentals/PALI.md
- SEC CIK: 0001357459
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:44 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001357459&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $500K | Sep 30, 2026 |
| Operating Income | TTM | -$48.13M | -9625.4% margin |
| Net Income | TTM | -$43.70M | -8739.2% net margin |
| Diluted EPS | TTM | -$0.21 | Split-adjusted |
| Free Cash Flow | TTM | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $113.6M | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $0 | $250K | $0 | -- | $14K | $15K | $260K | $260K | $16K |
| Research & Development | $10.19M | $16.00M | $6.89M | $6.55M | $2.43M | $2.02M | $4.06M | $3.96M | $8.10M | $13.16M |
| Total Operating Expenses | $18.06M | $14.86M | $13.32M | $15.72M | $41.85M | $9.30M | $8.65M | $8.52M | $13.57M | $20.65M |
| **Operating Income** | -$18.06M | -$14.86M | -$13.07M | -$15.72M | -$41.85M | -$9.30M | -$8.63M | -$8.26M | -$13.31M | -$20.64M |
| **EBITDA** | -$18.05M | -$14.86M | -$13.07M | -$15.72M | -$41.85M | -$9.29M | -$8.49M | -$8.07M | -$13.02M | -$20.30M |
| Interest Income | -- | -- | -- | -- | -- | $34K | $68K | $79K | $70K | $59K |
| Interest Expense | $10K | $12K | $15K | $13K | $2.40M | $235K | $8.9K | $7.7K | $159K | $1.14M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $1.0K | -- | -- | -- | $0 |
| **Net Income** | -$16.78M | -$14.44M | -$12.30M | -$14.26M | -$26.62M | -$10.32M | -$8.35M | -$4.92M | -$15.67M | -$21.07M |
| Basic EPS | -$0.30 | -$10.19 | -$27.01 | -$247.95 | -$2,144.25 | -$2,790.00 | -$2,850.00 | -$5,655.00 | -$900.00 | -$1,897.50 |
| **Diluted EPS** | -$0.30 | -$10.19 | -$27.01 | -$247.95 | -$2,546.10 | -$2,790.00 | -$2,850.00 | -$5,655.00 | -$900.00 | -$1,897.50 |
| Basic Shares Outstanding | 55.7M | 1.4M | 456.0K | 58.7K | 12.4K | 3.7K | 2.9K | 871 | 17.4K | 11.1K |
| Diluted Shares Outstanding | 55.7M | 1.4M | 456.0K | 58.7K | 12.5K | 3.7K | 2.9K | 871 | 17.4K | 11.1K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $500K | $0 | $0 | $0 | $0 | $0 | $0 |
| Research & Development | $12.00M | $6.00M | $6.00M | $6.17M | $1.39M | $1.68M | $950K | $2.08M |
| Total Operating Expenses | $15.70M | $12.20M | $10.75M | $9.98M | $2.92M | $2.84M | $2.31M | $3.38M |
| **Operating Income** | -$15.70M | -$11.70M | -$10.75M | -$9.98M | -$2.92M | -$2.84M | -$2.31M | -$3.38M |
| **EBITDA** | -$15.70M | -$11.70M | -$10.75M | -$9.98M | -$2.92M | -$2.84M | -$2.31M | -$3.38M |
| Interest Expense | $0 | $0 | $1.0K | $2.0K | $5.0K | $2.0K | $1.0K | $3.0K |
| **Net Income** | -$14.62M | -$10.57M | -$9.60M | -$8.90M | -$2.87M | -$2.78M | -$2.23M | -$3.34M |
| Basic EPS | -$0.07 | -$0.05 | -$0.05 | -- | -$0.38 | -$0.58 | -$0.47 | -- |
| **Diluted EPS** | -$0.07 | -$0.05 | -$0.05 | -- | -$0.38 | -$0.58 | -$0.47 | -- |
| Basic Shares Outstanding | 212.0M | 211.4M | 209.7M | -- | 7.5M | 4.8M | 4.8M | -- |
| Diluted Shares Outstanding | 212.0M | 211.4M | 209.7M | -- | 7.5M | 4.8M | 4.8M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $133.4M | $9.82M | $12.43M | $12.38M | $10.49M | $713K | $5.11M | $5.79M | $6.67M | $15.19M |
| Short-Term Investments | -- | -- | -- | -- | -- | -- | -- | -- | $5.00M | $5.00M |
| **Cash & Short-Term Investments** | $133.4M | $9.82M | $12.43M | $12.38M | $10.49M | $713K | $5.11M | $5.79M | $11.70M | $20.20M |
| Accounts Receivable, Net | $0 | $0 | -- | $0 | $0 | $59K | $21K | $294K | $313K | $10K |
| **Total Current Assets** | $134.2M | $10.49M | $13.33M | $14.73M | $11.51M | $896K | $5.65M | $6.51M | $12.45M | $20.90M |
| Property, Plant & Equipment, Net | $0 | $3.0K | $10K | $10K | $3.0K | $5.0K | $41K | $90K | $173K | $270K |
| Intangible Assets | -- | -- | -- | -- | -- | $147K | $669K | $764K | $883K | $990K |
| Other Non-Current Assets | $68K | $273K | $490K | $694K | $868K | -- | -- | $24K | $14K | $16K |
| **Total Non-Current Assets** | $123K | $386K | $724K | $1.03M | $1.01M | $2.12M | $937K | $1.18M | $1.44M | $1.70M |
| **Total Assets** | $134.3M | $10.88M | $14.05M | $15.76M | $12.51M | $3.02M | $6.58M | $7.68M | $13.88M | $22.60M |
| Accounts Payable | $767K | $1.10M | $698K | $1.76M | $1.32M | $2.54M | -- | -- | -- | -- |
| Short-Term Debt | -- | -- | -- | -- | $87K | $1.05M | -- | -- | -- | $3.71M |
| Other Current Liabilities | -- | -- | -- | -- | -- | -- | -- | $219K | $221K | $431K |
| **Total Current Liabilities** | $4.64M | $3.24M | $2.59M | $3.01M | $2.50M | $8.08M | $1.22M | $1.05M | $1.51M | $7.33M |
| Long-Term Debt | -- | -- | -- | -- | $0 | $94K | -- | -- | -- | -- |
| Other Non-Current Liabilities | -- | $150K | -- | -- | -- | -- | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $328K | $152K | $153K | $272K | $2.65M | $2.04M | $233K | $584K | $3.85M | $3.94M |
| **Total Liabilities** | $4.96M | $3.39M | $2.74M | $3.28M | $5.15M | $10.12M | $1.46M | $1.63M | $5.37M | $11.27M |
| **Total Debt (incl. Leases)** | -- | $90K | $211K | $316K | $199K | $1.42M | $149K | -- | -- | $3.71M |
| Common Stock | $1.59M | $27K | $6.0K | $30K | $3.0K | $28K | $39K | $9.1K | $152K | $110K |
| Retained Earnings | -- | $135.9M | $121.5M | $109.2M | $94.60M | -$68.03M | -$222.0M | -$213.6M | -$208.7M | -$193.0M |
| Accumulated Other Comp. Income | -- | -- | -- | -- | -- | -$734 | -$6.2K | -$413 | $2.6K | $3.9K |
| **Total Stockholders' Equity** | $129.4M | $7.49M | $11.31M | $12.48M | $7.37M | -$16.60M | -$8.33M | $6.05M | $8.52M | $11.33M |
| Total Equity | $129.4M | $7.49M | $11.31M | $12.48M | $7.37M | -$16.60M | -$8.33M | $6.05M | $8.52M | $11.33M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $113.6M | $125.2M | $132.6M | $133.4M | $5.23M | $5.42M | $7.23M | $9.82M |
| **Cash & Short-Term Investments** | $113.6M | $125.2M | $132.6M | $133.4M | $5.23M | $5.42M | $7.23M | $9.82M |
| Accounts Receivable, Net | -- | $500K | -- | $0 | -- | $0 | -- | $0 |
| **Total Current Assets** | $117.5M | $127.3M | $133.2M | $134.2M | $6.83M | $6.45M | $7.89M | $10.49M |
| Property, Plant & Equipment, Net | -- | -- | -- | $0 | $0 | $1.0K | $2.0K | $3.0K |
| Other Non-Current Assets | $1.02M | $0 | $17K | $68K | $119K | $171K | $222K | $273K |
| **Total Non-Current Assets** | $1.07M | $55K | $72K | $123K | $145K | $220K | $303K | $386K |
| **Total Assets** | $118.5M | $127.3M | $133.3M | $134.3M | $6.97M | $6.67M | $8.19M | $10.88M |
| Accounts Payable | $1.45M | $1.83M | $2.70M | $767K | $1.43M | $1.37M | $745K | $1.10M |
| **Total Current Liabilities** | $5.83M | $5.25M | $5.62M | $4.64M | $3.48M | $3.97M | $2.78M | $3.24M |
| Other Non-Current Liabilities | -- | -- | -- | -- | $283K | -- | -- | $150K |
| **Total Non-Current Liabilities** | $279K | $321K | $333K | $328K | $283K | $77K | $82K | $152K |
| **Total Liabilities** | $6.11M | $5.57M | $5.95M | $4.96M | $3.76M | $4.05M | $2.86M | $3.39M |
| **Total Debt (incl. Leases)** | -- | -- | -- | -- | -- | $24K | $58K | $90K |
| Common Stock | $1.74M | $1.74M | $1.67M | $1.59M | $91K | $48K | $43K | $27K |
| Retained Earnings | -- | -- | -- | -- | -- | $141.0M | $138.2M | $135.9M |
| **Total Stockholders' Equity** | $112.4M | $121.7M | $127.4M | $129.4M | $3.21M | $2.62M | $5.33M | $7.49M |
| Total Equity | $112.4M | $121.7M | $127.4M | $129.4M | $3.21M | $2.62M | $5.33M | $7.49M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$16.78M | -$14.44M | -$12.30M | -$14.26M | -$26.62M | -$10.32M | -$8.35M | -$4.92M | -$15.67M | -$21.07M |
| Depreciation & Amortization | $3.0K | $3.0K | $4.0K | $3.0K | $2.0K | $3.0K | $144K | $186K | $289K | $338K |
| Stock-Based Compensation | $3.96M | $652K | $624K | $1.03M | $1.89M | $2.01M | $881K | $634K | $1.77M | $3.45M |
| Change in Receivables | -- | -- | -- | $0 | $84K | -$59K | $273K | $19K | -$302K | $27K |
| **Operating Cash Flow** | -$10.85M | -$12.19M | -$11.13M | -$13.36M | -$14.77M | -$4.77M | -$7.26M | -$7.69M | -$13.42M | -$15.62M |
| Capital Expenditure | -- | $0 | -$4.0K | -$10K | $0 | -$6.0K | -- | -$1.7K | -$11K | -$98K |
| **Free Cash Flow** | -- | -$12.19M | -$11.14M | -$13.37M | -$14.77M | -$4.77M | -- | -$7.69M | -$13.43M | -$15.71M |
| Purchases of Investments | -- | -- | -- | -- | -- | -- | -- | -- | -$5.00M | -$5.00M |
| **Investing Cash Flow** | -- | $0 | -$4.0K | -$10K | -$54K | -$6.0K | -- | $5.00M | -$94K | $2.36M |
| Common Stock Issued | $128.2M | $8.44M | $9.42M | $14.40M | $5.21M | $1.18M | -- | -- | -- | -- |
| **Financing Cash Flow** | $134.4M | $9.58M | $11.19M | $15.26M | $24.61M | $1.89M | $6.59M | $1.81M | $4.99M | $23.74M |
| **Net Change in Cash** | $123.6M | -$2.61M | $49K | $1.89M | $9.78M | -$2.88M | -$672K | -$888K | -$8.52M | $10.48M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$14.62M | -$10.57M | -$9.60M | -$8.90M | -$2.87M | -$2.78M | -$2.23M | -$3.34M |
| Depreciation & Amortization | $0 | $0 | $0 | $0 | $1.0K | $1.0K | $1.0K | $0 |
| Stock-Based Compensation | $5.07M | $4.79M | $4.30M | $3.73M | $90K | $69K | $69K | $77K |
| **Operating Cash Flow** | -$11.76M | -$7.60M | -$3.89M | -$3.14M | -$3.55M | -$1.82M | -$2.33M | -$2.38M |
| Common Stock Issued | $200K | $0 | $3.25M | $128.2M | $0 | $0 | $0 | $4.43M |
| **Financing Cash Flow** | $200K | $147K | $3.13M | $131.3M | $3.36M | $4.0K | -$258K | $4.16M |
| **Net Change in Cash** | -$11.56M | -$7.46M | -$757K | $128.2M | -$190K | -$1.81M | -$2.59M | $1.78M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -- | -5228.0% | -- | -- | -68764.8% | -56071.8% | -3176.7% | -5118.1% | -127027.2% |
| **Net Profit Margin** | -- | -- | -4920.0% | -- | -- | -76346.2% | -54252.6% | -1894.1% | -6025.4% | -129721.8% |
| Return on Equity (ROE) | -13.0% | -192.7% | -108.7% | -114.3% | -361.4% | -- | -- | -81.4% | -184.0% | -186.0% |
| Return on Assets (ROA) | -12.5% | -132.7% | -87.5% | -90.5% | -212.7% | -341.9% | -126.8% | -64.1% | -112.8% | -93.2% |
| Current Ratio | 28.95x | 3.24x | 5.15x | 4.89x | 4.61x | 0.11x | 4.61x | 6.19x | 8.22x | 2.85x |
| Quick Ratio | 28.77x | 3.03x | 4.81x | 4.11x | 4.20x | 0.10x | 4.19x | 5.79x | 7.93x | 2.76x |
| Debt to Equity | -- | 0.01x | 0.02x | 0.03x | 0.03x | -- | -- | -- | -- | 0.33x |
| **Revenue Growth (YoY)** | -- | -100.0% | -- | -- | -- | -12.2% | -94.1% | 0.0% | +1500.4% | +56.0% |
| 5Y Revenue / Share Growth | -100.0% | -100.0% | -99.8% | -100.0% | -- | +227.0% | +3139.3% | +26052.5% | +183.9% | -75.9% |
| 10Y Revenue / Share Growth | -100.0% | -100.0% | -52.0% | -100.0% | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -9625.4% | -7069.8% | -- | -- | -- | -- | -- | -- |
| **Net Profit Margin** | -8739.2% | -6388.2% | -- | -- | -- | -- | -- | -- |
| Return on Equity (ROE) | -38.9% | -26.2% | -19.0% | -13.0% | -349.5% | -452.1% | -246.5% | -192.7% |
| Return on Assets (ROA) | -36.9% | -25.1% | -18.1% | -12.5% | -161.0% | -177.7% | -160.5% | -132.7% |
| Current Ratio | 20.16x | 24.26x | 23.71x | 28.95x | 1.96x | 1.62x | 2.84x | 3.24x |
| Quick Ratio | 19.50x | 23.96x | 23.60x | 28.77x | 1.50x | 1.36x | 2.60x | 3.03x |
| Debt to Equity | -- | -- | -- | -- | -- | 0.01x | 0.01x | 0.01x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
